Outcome analysis of patients with squamous cell carcinoma of the head and neck and hepatitis C virus

Laryngoscope

Volumn 115, Issue 10 I, 2005, Pages 1882-1886

  Hunt, Jason ^a,b   Hagan, Joseph ^a,b   Nobles, James ^a   Wold, Christian ^a   Fazekas May, Mary ^a   Gilbert, Jill ^a   Friedlander, Paul L ^a,b  

^a LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Head and neck neoplasm; Hepatitis C virus; Outcomes analysis; Squamous cell carcinoma

Indexed keywords

ALBUMIN; VIRUS RNA;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CANCER SURVIVAL; COMORBIDITY; CONTROLLED STUDY; COX REGRESSION ANALYSIS; FEMALE; HEAD AND NECK CARCINOMA; HEMATOCRIT; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; STUDENT T TEST; VIRUS LOAD;

AGED; CARCINOMA, SQUAMOUS CELL; FEMALE; HEAD AND NECK NEOPLASMS; HEPACIVIRUS; HEPATITIS C; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 26944480015     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000177991.03841.27     Document Type: Article

References (13)

1. Zeka A, Gore R, Kriebel D. Effects of alcohol and tobacco on aerodigestive cancer risks: a meta-regression analysis. Cancer Causes Control 2003;14:897-906.
2. Mineta H, Ogino T, Amano HM, et al. Human papilloma virus (HPV) type 16 and 18 detected in head and neck squamous cell carcinoma. Anticancer Res 1998;18:4765-4768.
3. Haraf DJ, Nodzenski E, Brachman D, et al. Human papilloma virus and p53 in head and neck cancer: clinical correlates and survival. Clin Cancer Res 1996;2:755-762.
4. Field JK. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol 1992;28B:67-76.
5. Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med 1999;341:556-562.
6. Mishra G, Sninsky C, Roswell R, et al. Risk factors for hepatitis C virus infection among patients receiving health care in a Department of Veterans Affairs hospital. Dig Dis Sci 2003;48:815-820.
7. Nobles J, Wold C, Fazekas-May M, et al. Prevalence and epidemiology of hepatitis C virus in patients with squamous cell carcinoma of the head and neck. Laryngoscope 2004;114:2119-2122.
8. Pawlotsky JM. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res 2003;59:1-11.
9. Conry-Cantilena C, VanRaden M, Gibble J, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996; 334:1691-1696.
10. Altintepe L, Kurtoglu E, Tonbul Z, et al. Lower erythropoietin and iron supplementation are required in hemodialysis patients with hepatitis C virus infection. Clin Nephrol 2004;61:347-351.
11. Ong YK, Heng DM, Chung B, et al. Design of a prognostic index score for metastatic nasopharyngeal carcinoma. Eur J Cancer 2003;39:1535-1541.
12. Wessely S, Pariante C. Fatigue, depression and chronic hepatitis C infection. Psychol Med 2002;32:1-10.
13. Swango PA. Cancers of the oral cavity and pharynx in the United States: an epidemiologic overview. J Public Health Dent 1996;56:309-318.